IL70771A0 - Pharmaceutical compositions containing nafazatrom - Google Patents
Pharmaceutical compositions containing nafazatromInfo
- Publication number
- IL70771A0 IL70771A0 IL70771A IL7077184A IL70771A0 IL 70771 A0 IL70771 A0 IL 70771A0 IL 70771 A IL70771 A IL 70771A IL 7077184 A IL7077184 A IL 7077184A IL 70771 A0 IL70771 A0 IL 70771A0
- Authority
- IL
- Israel
- Prior art keywords
- nafazatrom
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- containing nafazatrom
- Prior art date
Links
- ISBUYSPRIJRBKX-UHFFFAOYSA-N 5-methyl-2-(2-naphthalen-2-yloxyethyl)-4h-pyrazol-3-one Chemical compound O=C1CC(C)=NN1CCOC1=CC=C(C=CC=C2)C2=C1 ISBUYSPRIJRBKX-UHFFFAOYSA-N 0.000 title 1
- 229950011492 nafazatrom Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833302811 DE3302811A1 (de) | 1983-01-28 | 1983-01-28 | Verwendung von nafazatrom bei der therapie von herzrhythmusstoerungen und myokardischaemien, arzneimittel hierfuer und verfahren zu deren herstellung |
| DE19833308880 DE3308880A1 (de) | 1983-03-12 | 1983-03-12 | Verwendung von nafazatrom als lipoxygenasehemmer, bei der therapie von herzrhythmusstoerungen und ischaemien, sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL70771A0 true IL70771A0 (en) | 1984-04-30 |
Family
ID=25807873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL70771A IL70771A0 (en) | 1983-01-28 | 1984-01-25 | Pharmaceutical compositions containing nafazatrom |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US4540707A (en, 2012) |
| EP (1) | EP0115789B1 (en, 2012) |
| DE (1) | DE3481403D1 (en, 2012) |
| DK (1) | DK39584A (en, 2012) |
| ES (1) | ES529236A0 (en, 2012) |
| FI (1) | FI840327A7 (en, 2012) |
| GR (1) | GR81959B (en, 2012) |
| HU (1) | HU197213B (en, 2012) |
| IL (1) | IL70771A0 (en, 2012) |
| NO (1) | NO840113L (en, 2012) |
| PH (1) | PH20369A (en, 2012) |
| PT (1) | PT77971B (en, 2012) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169185A (en) * | 1991-01-25 | 1992-12-08 | Republic Industries, Inc. | Panic exit device featuring improved bar movement and fail safe dogging |
| CA2489552A1 (en) * | 2002-06-28 | 2004-01-08 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4372887A (en) * | 1970-06-18 | 1983-02-08 | Mead Johnson & Company | Iminopyrrolidinylindoles |
| DE2427272C3 (de) * | 1974-06-06 | 1981-10-01 | Bayer Ag, 5090 Leverkusen | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum |
| DE3118126A1 (de) * | 1981-05-07 | 1982-12-02 | Bayer Ag, 5090 Leverkusen | Sulfenamide zur verwendung in arzneimitteln |
| US4432991A (en) * | 1981-07-13 | 1984-02-21 | American Cyanamid Company | Therapeutically active 3-amino-1-phenyl(and substituted phenyl)-2-pyrazolines |
-
1983
- 1983-04-18 US US06/486,175 patent/US4540707A/en not_active Expired - Fee Related
-
1984
- 1984-01-12 NO NO840113A patent/NO840113L/no unknown
- 1984-01-13 EP EP84100305A patent/EP0115789B1/de not_active Expired - Lifetime
- 1984-01-13 DE DE8484100305T patent/DE3481403D1/de not_active Expired - Lifetime
- 1984-01-18 PT PT77971A patent/PT77971B/pt unknown
- 1984-01-25 PH PH30164A patent/PH20369A/en unknown
- 1984-01-25 IL IL70771A patent/IL70771A0/xx unknown
- 1984-01-26 GR GR73625A patent/GR81959B/el unknown
- 1984-01-26 FI FI840327A patent/FI840327A7/fi not_active Application Discontinuation
- 1984-01-27 DK DK39584A patent/DK39584A/da not_active Application Discontinuation
- 1984-01-27 HU HU84375A patent/HU197213B/hu not_active IP Right Cessation
- 1984-01-27 ES ES529236A patent/ES529236A0/es active Granted
-
1985
- 1985-03-25 US US06/715,438 patent/US4657924A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK39584A (da) | 1984-07-29 |
| PH20369A (en) | 1986-12-04 |
| PT77971A (en) | 1984-02-01 |
| DK39584D0 (da) | 1984-01-27 |
| EP0115789B1 (de) | 1990-02-28 |
| EP0115789A3 (en) | 1987-07-15 |
| NO840113L (no) | 1984-07-30 |
| DE3481403D1 (de) | 1990-04-05 |
| ES8500055A1 (es) | 1984-10-01 |
| PT77971B (en) | 1986-07-15 |
| FI840327A0 (fi) | 1984-01-26 |
| GR81959B (en, 2012) | 1984-12-12 |
| US4657924A (en) | 1987-04-14 |
| FI840327A7 (fi) | 1984-07-29 |
| HUT34886A (en) | 1985-05-28 |
| EP0115789A2 (de) | 1984-08-15 |
| HU197213B (en) | 1989-03-28 |
| US4540707A (en) | 1985-09-10 |
| ES529236A0 (es) | 1984-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2136807B (en) | Pharmaceutical compositions | |
| GB8423339D0 (en) | Pharmaceutical compositions | |
| GB8403668D0 (en) | Pharmaceutical compositions | |
| DE3467703D1 (en) | Pharmaceutical compositions | |
| GB8313217D0 (en) | Pharmaceutical compositions | |
| GB8415975D0 (en) | Pharmaceutical compositions | |
| GR80445B (en) | Pharmaceutical compositions | |
| GB8308126D0 (en) | Pharmaceutical compositions | |
| GB8423800D0 (en) | Pharmaceutical compositions | |
| GB8427485D0 (en) | Pharmaceutical compositions | |
| GB2136806B (en) | Pharmaceutical compositions | |
| GB8414458D0 (en) | Pharmaceutical compositions | |
| CY1503A (en) | Pharmaceutical compositions | |
| GB8412569D0 (en) | Pharmaceutical compositions | |
| GR80223B (en) | Pharmaceutical compositions | |
| GB8406132D0 (en) | Pharmaceutical compositions | |
| GR80238B (en) | Pharmaceutical compositions | |
| GB8416358D0 (en) | Pharmaceutical compositions | |
| GB8300767D0 (en) | Pharmaceutical compositions | |
| GB8305697D0 (en) | Pharmaceutical compositions | |
| IL70771A0 (en) | Pharmaceutical compositions containing nafazatrom | |
| GB8425250D0 (en) | Pharmaceutical compositions | |
| GB2150435B (en) | Pharmaceutical compositions | |
| GB8304870D0 (en) | Pharmaceutical compositions | |
| GB8301718D0 (en) | Pharmaceutical compositions |